Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 33 (31) 3598-3607
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
This research was also supported by funds from Pharmacia & Upjohn Company, now Pfizer Oncology.
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Prevention
Sec. Committees:
GI    
Pharmas:
 
Grants:
U10CA037447, U10 CA032291, CA33601, R01 CA118553, R01 CA149222, CA32291, U10 CA045808, R01-CA169141, U10 CA031946, CA77651, UG1 CA189974, U10 CA033601, CA180820, CA60138, U10 CA180821, R01-CA118553, CA45808, U10CA180882, P30 CA060553, P50-CA127003, R01-CA149222, UG1 CA189823, U10 CA077651, R01 CA169141, U10 CA180882, U10 CA180820, U10CA180821, U10 CA180867, U10 CA180888, P50 CA127003, CA31946  
Corr. Author:
 
Authors:
                                           
Networks:
CA136, LAPS-CT018, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC010, LAPS-NY016, NC031, NY167, OH016   
Study
Alliance-89803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
Keywords:
Gic1, Gic2, To15, ORIGINAL REPORTS, Gastrointestinal Cancer